Connect with others who understand.

sign up log in
Resources
About MyMyelomaTeam

Connect with others who understand.

sign up log in
Resources
About MyMyelomaTeam

Treatments for Myeloma

Updated on December 06, 2021
Medically reviewed by
Todd Gersten, M.D.
Article written by
Kelly Crumrin

There are now more therapies for multiple myeloma than ever before, with new treatments under development in clinical trials. Hematologists-oncologists (blood disease and cancer specialists) recommend treatments they think will be most effective based on the type and stage of myeloma you have, what treatments you’ve tried, and how your myeloma has responded to previous treatments. Oncologists also take into account your age, overall health, and any other conditions you may have. Ultimately, the choice of your myeloma treatment is up to you.

In most cases, multiple myeloma is not curable. The majority of people with multiple myeloma experience a relapse at some point. The effectiveness of new medications and regimens means that, for many people, myeloma is a chronic condition that can be managed with treatment. Some myeloma medications are so new that long-term data is not yet available. However, survival rates for people with multiple myeloma continue to improve.

Types of Treatment for Myeloma

In the early stages of myeloma and related conditions, such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), doctors typically recommend watchful waiting with periodic tests and examinations. If test results show myeloma is progressing, doctors may then recommend beginning treatment. In some cases, when myeloma cells are found to have specific genetic characteristics that carry a high risk for progression, doctors may recommend those with SMM begin treatment sooner.

Myeloma treatments generally fall into a few main categories:

  • Chemotherapy and other antimyeloma medications
  • Radiation therapy
  • Stem cell transplants
  • Surgeries
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Supportive treatments

Most cases of myeloma are treated with a combination of treatments. Healthy lifestyle choices, such as a nutritious diet and regular exercise, can help those with myeloma feel their best and recover from treatment more readily.

Read details about specific treatments for myeloma.

Chemotherapy and Antimyeloma Drugs for Multiple Myeloma

Chemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells. High-dose chemotherapy followed by autologous stem cell transplant is a common treatment for people when they are first diagnosed with multiple myeloma. Certain chemotherapy drugs must be infused intravenously (by IV), while others are injected or taken orally.

Chemotherapy is usually prescribed by a medical oncologist — a doctor who specializes in treating cancer with medications. Some doctors may refer to all medication prescribed for someone with myeloma as chemotherapy. Chemotherapy is often given in three phases: induction therapy (also called initial therapy), consolidation therapy, and maintenance therapy. Different drugs or doses may be used during each phase.

There are many classes of chemotherapy drugs for myeloma. Most chemotherapy drugs used for myeloma are given in combinations of two or more drugs. The regimen depends on the type of myeloma you have, the stage of your myeloma, whether you have tried other therapies before, and whether or not you are going to receive a stem cell transplant. Since many chemotherapy regimens for multiple myeloma involve three drugs, they are commonly referred to as “triplets.”

If your myeloma progresses, or if you experience significant side effects, your medical oncologist may adjust your dosage or change the combination of drugs you receive. Some chemotherapy drugs are approved by the U.S. Food and Drug Administration (FDA) to treat all cases of myeloma. Others are only approved to treat myeloma that is refractory (resistant to treatment) or relapsed (returned after being treated).

Classes of chemotherapy drugs used for myeloma include:

  • Alkylating agents — These drugs are thought to prevent the growth of cancer cells by inhibiting and damaging their DNA. They include Alkeran (melphalan), Cytoxan (cyclophosphamide), Pepaxto (melphalan flufenamide), BiCNU (carmustine), and Treanda (bendamustine).
  • Anthracyclines — These treatments slow the growth of cancer cells by interfering with cell division. They include Adriamycin (doxorubicin) and Doxil (doxorubicin hydrochloride liposome).
  • Proteasome inhibitors — Proteasome inhibitors such as Kyprolis (carfilzomib), Ninlaro (ixazomib), and Velcade (bortezomib) prevent myeloma cells from destroying extra proteins. When too many proteins build up and the cell can’t remove them, the cell dies.
  • Histone deacetylase (HDAC) inhibitors — Farydak (panobinostat) and other HDAC inhibitors change which genes are turned on or off in cancer cells.

Another myeloma drug, Xpovio (selinexor), is in a new class of medications that prevent cancer cells from properly transporting proteins.

Chemotherapy medications may be combined with other classes of drugs, including corticosteroids — such as dexamethasone and prednisone — or immunomodulatory drugs such as Thalomid (thalidomide), Revlimid (lenalidomide), and Pomalyst (pomalidomide).

Monoclonal antibodies are genetically engineered proteins that can kill cancer cells directly or aid the immune system in targeting and destroying cancer cells. Monoclonal antibodies approved to treat myeloma include:

If you are taking chemotherapy drugs orally, you can do so at home. If you are taking chemotherapy drugs intravenously, you will usually need to receive them in a clinical setting like a doctor’s office or cancer treatment center. You may receive them through a slow-drip IV infusion in your hand or arm, or as an intramuscular (into the muscle) or subcutaneous (under the skin) injection. You may also have a line or a port — a small, flexible tube — implanted temporarily beneath the skin to allow for chemotherapy access.

A course of chemotherapy is administered in cycles of treatment and recovery. Most people with myeloma will receive around four cycles of chemotherapy in one complete course, although some treatment plans include 12 cycles or more. The initial course of chemotherapy usually lasts four to six months. After this time, another treatment option like a stem cell transplant or additional cycles of chemotherapy may be used.

During treatment, chemotherapy is administered for several hours over consecutive days. Each period of treatment will be followed by a recovery period of a few weeks to allow your body to rest. Your medical oncologist will determine your chemotherapy schedule based on many factors, including the type and stage of your myeloma, how well your cancer responds to treatment, and the severity of the side effects you experience.

Chemotherapy Side Effects

Each class of chemotherapy drugs causes different side effects, some of which are very serious. What side effects you experience will depend on many factors: the drug combination your doctor prescribes, your dosage, and how well your body can tolerate the treatment.

If you cannot tolerate the side effects, your doctor may try decreasing dosage or changing the combination in an effort to minimize danger and discomfort. Always report side effects to your doctor. Some side effects, such as nausea, can be eased with other medications.

Some of the most common side effects of chemotherapy include:

  • Fatigue
  • Nausea
  • Vomiting
  • Diarrhea
  • Loss of appetite
  • Weight loss
  • Hair loss
  • Skin problems
  • Mouth sores

Damage to bone marrow often results in a weakened immune system due to low white blood cell counts. Some chemotherapy drugs can cause neuropathy, or nerve damage. This may result in pain, tingling, or numbness in the extremities. These symptoms may be temporary or permanent.

Some people report cognitive side effects from chemotherapy, such as memory problems and trouble focusing or planning. These cognitive issues are sometimes referred to as “chemo brain.” These side effects usually disappear soon after the end of treatment, although fatigue may last for years after treatment is over.

Chemotherapy treatment also affects male and female reproduction in many ways, both temporary and permanent. Other serious late-term side effects of chemotherapy for myeloma can include damage to the heart and lungs, early menopause, and a higher risk for developing other cancers.

Stem Cell Transplants for Multiple Myeloma

Stem cell transplant after high-dose chemotherapy is a common treatment for people when they are first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace cancerous bone marrow cells with stem cells that will form healthy bone marrow. Stem cell transplants take place after the cancerous cells of the bone marrow have been destroyed with chemotherapy, radiation, or a combination of the two.

In the past, cells for transplant were taken from bone marrow. For this reason, some people still refer to stem cell transplants as bone marrow transplants. However, blood is now the most common source for stem cells for transplant in cases of multiple myeloma.

Autologous vs. Allogeneic Stem Cell Transplants

There are two types of stem cell transplant: autologous stem cell transplant and allogeneic stem cell transplant. The majority of people with multiple myeloma receive an autologous stem cell transplant. In an autologous stem cell transplant, stem cells are harvested from the person’s own body. Autologous transplants are preferable in most cases because the cells will not attack the body. The risk with autologous stem cell transplants is that the peripheral blood stem cells may be contaminated with myeloma cells, which may contribute to a later relapse. Autologous stem cell transplantation cannot cure myeloma.

For those who will receive autologous stem cell transplants, their peripheral blood stem cells are harvested before they begin chemotherapy or early in the cycle. The cells are then frozen until they are needed for the transplant.

Less commonly, an allogeneic stem cell transplant may be considered. In an allogeneic transplant, stem cells are harvested from a donor. This is usually a sibling or close blood relative, but sometimes it’s an unrelated person who is a good genetic match. Allogeneic transplants can cure myeloma in some cases, but they carry a high risk of severe side effects and death.

Ideally, allogeneic stem cell transplants will trigger a process known as graft-versus-tumor or graft-versus-myeloma effect in which the transplanted cells help attack the cancer cells and potentially cure myeloma. However, the greater risk of graft-versus-host disease (GVHD) often outweighs this potential benefit of allogeneic stem cell transplant. In GVHD, the transplanted donor cells attack the host’s tissues. The effects of GVHD can range from mild, chronic symptoms to life-threatening emergencies.

How Do Stem Cell Transplants Work?

The process of receiving a stem cell transplant is similar to receiving a blood transfusion. Stem cell transplants for multiple myeloma may be administered on an outpatient or inpatient basis. Between 30 percent and 40 percent of people with myeloma undergo outpatient stem cell transplants, with daily monitoring for side effects. The majority of people will be admitted to the hospital during the stem cell transplant process. Those admitted to the hospital for stem cell transplant can expect to stay two to three weeks during recovery.

During the first weeks of recovery from stem cell transplant, people with myeloma may receive antibiotics and antiviral or antifungal medications to protect against infection. They may also require transfusions of red blood cells or platelets (cell fragments involved in the clotting process) to replace those destroyed by chemotherapy. Those who have undergone stem cell transplant for multiple myeloma are often given Erythropoietin (EPO), a hormone that encourages and speeds the growth of red blood cells.

Side Effects of Stem Cell Transplants

Short-term side effects of stem cell transplant can include:

  • Fatigue
  • Headaches
  • Fever and chills
  • Nausea
  • Vomiting
  • Diarrhea
  • Loss of appetite
  • Weight loss
  • Trouble sleeping
  • Skin rashes

Some people develop mucositis, an inflammation of the digestive tract that can cause pain and make it difficult to eat. Some side effects, such as nausea, can be eased with other medications. Fatigue may be longer-lasting, persisting beyond the immediate recovery period. It may take months to fully recover after receiving a stem cell transplant.

After receiving an autologous stem cell transplant, people with multiple myeloma will receive several years of maintenance medications to sustain the treatment response. People who receive allogeneic stem cell transplants may need to take antirejection medication for life.

Radiation Therapy

Radiation therapy (also called radiotherapy) is commonly used to treat solitary plasmacytoma — a single lesion in the bone or soft tissues. Radiotherapy may be used as the only treatment for plasmacytoma, or it may be given during or after surgery to remove lesions. Radiation therapy may also be used to treat multiple myeloma in cases where chemotherapy has been ineffective at reducing pain in a limited number of bone sites. Radiotherapy is overseen by a radiation oncologist.

Radiation interferes with cell division. Since cancer cells divide much more rapidly than normal cells, they are more vulnerable to radiation. Radiation kills cancer cells, while the normal, healthy cells of your body are better able to survive and heal. Radiation therapy can help shrink tumor size, can slow or prevent the spread of tumors, and may strengthen the bone and help treat pain.

Radiation schedules differ based on the size, location, and type of tumor; other treatments you are receiving; and additional factors. Radiation therapy is usually delivered five days a week during the treatment period, which is most commonly about two to four weeks. Receiving the treatment takes about 30 minutes, but it may take longer to prepare for the procedure.

Radiation Therapy Side Effects

Most common side effects of external beam radiation are short-term. These include fatigue, swelling, nausea, diarrhea, and skin damage similar to sunburn. These changes are usually gone within six to 12 months after radiation treatment ceases, but they may linger for as long as two years. Less common side effects include nerve damage that can leave parts of the body feeling painful, weak, or numb. A very rare but serious side effect of external beam radiation can include developing a different type of cancer called angiosarcoma.

Surgery

In some cases of solitary plasmacytoma, extramedullary myeloma (plasma cell tumors located outside of the bones), or localized myeloma, your doctor may recommend surgical resection — cutting away the lesion or removing the tumor from the healthy bone or tissue.

In those whose myeloma has affected the pelvis or the spine, hip replacement or spinal surgery may relieve pain and restore the ability to walk.

Chimeric Antigen Receptor T-Cell Therapy

CAR T-cell therapy is a type of immunotherapy that enables the body’s own immune system to better fight cancer. A form of CAR T-cell therapy called Abecma (idecabtagene vicleucel) has been approved to treat myeloma. During CAR T-cell therapy, doctors remove a person’s T cells (a type of white blood cell). The T cells are genetically engineered in a lab — they are “trained” to recognize a protein called BCMA that is found on the surface of myeloma cells. Once the T cells are ready, they are returned to the person with myeloma, where they begin attacking cancerous plasma cells.

Supportive Treatments for Multiple Myeloma

Some treatments are not prescribed to fight myeloma but to reduce symptoms of the condition and the side effects of treatments. Supportive care can include medications and medical procedures. The goal of supportive treatments is to improve functionality and quality of life, and to reduce the severity of side effects.

Pain is a common symptom of myeloma and a side effect of many myeloma treatments. Opioids may be prescribed to treat pain, including:

Opioids are believed to work by reducing the perception of pain. Treatments like radiation therapy and surgery may also help relieve bone pain.

Anticonvulsants, such as Neurontin (gabapentin) and Lyrica (pregabalin), or antidepressants, including Cymbalta (duloxetine), Elavil (amitriptyline), and Norpramin (desipramine), may be used to treat neuropathy (nerve pain) caused by chemotherapy. Anticonvulsants reduce pain signals sent by damaged nerves. Antidepressants are believed to work by changing the balance of neurotransmitters (chemicals that transmit messages) in the brain. Most people with myeloma should avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, because drugs in this class can negatively affect the kidneys.

Medical marijuana may be prescribed to treat pain, nausea, vomiting, loss of appetite, and insomnia in people with multiple myeloma.

Bisphosphonates, such as Aredia (pamidronate) and Zometa (zoledronic acid), can reduce the risk of complications related to bone lesions in some people with myeloma. Xgeva (denosumab) is a biologic drug that helps reduce the risk of spinal fractures and spinal cord compression in people whose spines have been weakened by myeloma.

Flu and pneumonia vaccines are recommended for people with myeloma and those who spend time with them. The immune systems of those with myeloma are compromised, and certain vaccines can help protect them from infection.

People with myeloma who develop anemia — low levels of red blood cells — may be given a blood transfusion or EPO.

Many people with myeloma develop low levels of normal immunoglobulins — also known as antibodies — that recognize and destroy specific viruses and other threats. If antibody levels become too low, doctors sometimes recommend intravenous immunoglobulin (IVIG) to bolster the immune system and help protect against infection. IVIG is produced by pooling antibodies from thousands of blood donors. IVIG is administered by IV in a medical setting. IVIG treatment is commonly given once a month while antibody levels are low.

In some cases of myeloma, cancer cells secrete large amounts of abnormal, ineffective antibodies called M protein or monoclonal protein, leading to the development of complications like amyloidosis or light chain deposition disease. These conditions can damage the kidneys and interfere with blood flow.

Plasmapheresis (plasma exchange) is a short-term treatment for acute kidney damage in people with myeloma. Plasmapheresis involves replacing the plasma, or liquid part of your blood, with albumin or plasma from a donor. The plasma and abnormal antibodies are removed, and your red and white blood cells are combined with the replacement plasma and returned to your body. Plasma exchange works by reducing the amount of abnormal immunoglobulins in the blood.

In about 10 percent of people with multiple myeloma, abnormal proteins cause kidney damage severe enough to require kidney replacement therapy. Dialysis is the most common type of kidney replacement therapy. There are two main types of dialysis, hemodialysis and peritoneal dialysis. Both types of dialysis provide a means of filtering waste products from the blood, taking over the role from the failing kidneys.

Are There Natural Treatments for Myeloma?

No natural, alternative treatments have been proven effective in clinical studies to treat myeloma. However, many people have found various complementary or alternative therapies effective for managing myeloma symptoms and side effects of myeloma treatment, such as pain, fatigue, nausea, anxiety, and depression.

Some people have reported feeling better after therapies such as acupuncture, acupressure, or aromatherapy. Dietary supplements (including L-glutamine, the Japanese herb goshajinkigan, or omega-3 fatty acids) may also have a beneficial effect. However, since some natural or complementary treatments can interfere with myeloma medications or cause their own side effects, it is important to talk to your health care team before trying any.

Read more about natural and alternative therapies for myeloma.

Financial Assistance for Myeloma Treatments

Treatment of multiple myeloma can be very expensive. Some manufacturers of antimyeloma medications offer copay assistance programs for people with health insurance who have trouble affording their copay. Some people with low income and no health insurance qualify for programs that provide free medication.

Several nonprofit foundations offer guides to help find assistance paying for myeloma medications. Visit the links below for more information:

Condition Guide

References
  1. Clinical Trials and Experimental Therapies — Multiple Myeloma Research Foundation
  2. About Multiple Myeloma — UCSF Helen Diller Family Comprehensive Cancer Center
  3. Watchful Waiting for Multiple Myeloma — Canadian Cancer Society
  4. When To Initiate Treatment in Smoldering Multiple Myeloma — Clinical Advances in Hematology & Oncology
  5. Multiple Myeloma: Types of Treatment — Cancer.Net
  6. First Treatment for Myeloma — Cancer Research UK
  7. Drug Therapy for Multiple Myeloma — American Cancer Society
  8. Triplet Therapy: A New Standard for Multiple Myeloma — Journal of Oncology Navigation & Survivorship
  9. Chemotherapy and Drug Therapy — Myeloma — Leukemia & Lymphoma Society
  10. Current FDA-Approved Medications — International Myeloma Foundation
  11. Proteasome Inhibitors — Multiple Myeloma Research Foundation
  12. Chemotherapy — Macmillan Cancer Support
  13. Multiple Myeloma Treatment Regimens — Cancer Therapy Advisor
  14. How Cancer And Cancer Treatment Can Affect Fertility in Males — American Cancer Society
  15. How Cancer and Cancer Treatment Can Affect Fertility in Females — American Cancer Society
  16. Stem Cell Transplant for Multiple Myeloma — American Cancer Society
  17. Stem Cell Transplants — Multiple Myeloma Research Foundation
  18. Graft-Versus-Host Disease — Leukemia & Lymphoma Society
  19. Stem Cell or Bone Marrow Transplant Side Effects — American Cancer Society
  20. Mucositis Associated With Stem Cell Transplantation: Current Status and Innovative Approaches to Management — Bone Marrow Transplantation
  21. Experience of Severe Fatigue in Long-term Survivors of Stem Cell Transplantation — Bone Marrow Transplantation
  22. Radiation Therapy for Multiple Myeloma — American Cancer Society
  23. Radiation Therapy – Leukemia & Lymphoma Society
  24. Surgery for Multiple Myeloma — American Cancer Society
  25. Chimeric Antigen Receptor (CAR) T-Cell Therapy — Leukemia & Lymphoma Society
  26. FDA Approves Novel CAR T-Immunotherapy for the Treatment of Multiple Myeloma — Leukemia & Lymphoma Society
  27. Integrative Care — Cancer Treatment Centers of America
  28. Supportive Care and Disease Complications — Myeloma — Leukemia & Lymphoma Society
  29. Pain Management for Multiple Myeloma — Memorial Sloan Kettering Cancer Center
  30. Pain Management in Patients With Multiple Myeloma: An Update — Cancers
  31. Marijuana and Cancer — American Cancer Society
  32. Flu Shots and Immunizations — Leukemia & Lymphoma Society
  33. Supportive Treatments for Patients With Multiple Myeloma — American Cancer Society
  34. Treatment of Multiple Myeloma With Renal Involvement: The Nephrologist’s View — Clinical Kidney Journal
  35. Natural Products and Complementary Therapies for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review — Critical Reviews in Oncology/Hematology
All updates must be accompanied by text or a picture.
Todd Gersten, M.D. is a hematologist-oncologist at the Florida Cancer Specialists & Research Institute in Wellington, Florida. Review provided by VeriMed Healthcare Network. Learn more about him here.
Kelly Crumrin is a senior editor at MyHealthTeam and leads the creation of content that educates and empowers people with chronic illnesses. Learn more about her here.

Related articles

Every myeloma therapy option comes with potential benefits and potential risks.Your doctor will...

Weighing the Risks and Benefits of Myeloma Treatment Options

Every myeloma therapy option comes with potential benefits and potential risks.Your doctor will...
People with multiple myeloma may face myriad challenges, including health care disparities and...

How Would You Use $100,000 To Improve Myeloma Care?

People with multiple myeloma may face myriad challenges, including health care disparities and...
Most people with multiple myeloma need to undergo treatment. How do you know if these treatments...

What Is Minimal Residual Disease in Myeloma?

Most people with multiple myeloma need to undergo treatment. How do you know if these treatments...
Stem cell transplants are often used to treat multiple myeloma. This type of treatment has been...

Stem Cell Transplants for Multiple Myeloma: Your Guide

Stem cell transplants are often used to treat multiple myeloma. This type of treatment has been...
Blood cancers such as multiple myeloma are often treated with anti-cancer drugs called...

Chemotherapy for Multiple Myeloma: Your Guide

Blood cancers such as multiple myeloma are often treated with anti-cancer drugs called...
If you have myeloma, you may be curious about the role vitamin D plays in your overall health. As...

Vitamin D and Myeloma: Benefits and Uses

If you have myeloma, you may be curious about the role vitamin D plays in your overall health. As...

Recent articles

Working while undergoing treatment for multiple myeloma is a personal decision with several...

Working With Multiple Myeloma

Working while undergoing treatment for multiple myeloma is a personal decision with several...
Thanks to years of cancer research and public-health messaging, most people understand that...

Smoking and Multiple Myeloma

Thanks to years of cancer research and public-health messaging, most people understand that...
Around 63 percent of people newly diagnosed with myeloma are also living with — or have a history...

Understanding Heart Disease and Myeloma Treatment

Around 63 percent of people newly diagnosed with myeloma are also living with — or have a history...
Multiple myeloma is a cancer in which white blood cells called plasma cells develop abnormalities...

Myeloma and Ethnicity: Is Race a Risk Factor in Multiple Myeloma?

Multiple myeloma is a cancer in which white blood cells called plasma cells develop abnormalities...
Feelings of worry, fear, and anxiety are common when living with cancer such as myeloma. In fact,...

Managing Anxiety and Myeloma

Feelings of worry, fear, and anxiety are common when living with cancer such as myeloma. In fact,...
People with multiple myeloma at any stage can benefit from palliative care. This type of care can...

Palliative Care: Improving Quality of Life With Myeloma at Any Stage

People with multiple myeloma at any stage can benefit from palliative care. This type of care can...
MyMyelomaTeam My myeloma Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close